You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-thrombotic agents

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type2 Diabetes, Coronary Heart Disease Trial in Portugal (Exposure to Anti-thrombotic treatment agents and glucose lowering

Active, not recruiting
  • Type2 Diabetes Mellitus
  • Coronary Heart Disease
  • Exposure to Anti-thrombotic treatment agents and glucose lowering therapy
  • Amadora, Lisbon, Portugal
  • +11 more
Oct 26, 2021

Stroke, Medication Adherence Trial in Kumasi (Polycap)

Not yet recruiting
  • Stroke
  • Medication Adherence
  • Kumasi, Ghana
    Kwame Nkrumah Institute of Science & Technology
Jul 19, 2023

Coronary Artery Ectasia Trial (Rivaroxaban 2.5 Mg Oral Tablet twice daily, Clopidogrel 75 Mg Oral Tablet, Aspirin tablet 75 mg)

Not yet recruiting
  • Coronary Artery Ectasia
  • Rivaroxaban 2.5 Mg Oral Tablet twice daily
  • +2 more
  • (no location specified)
Jan 30, 2023

Acute Ischemic Stroke Trial in Houston (Thrombolytic Agent)

Recruiting
  • Acute Ischemic Stroke
  • Thrombolytic Agent
  • Houston, Texas
    Michael E. DeBakey VA Medical Center
Jun 8, 2022

Surgery, Perioperative/Postoperative Complications Trial in Dallas

Active, not recruiting
  • Surgery
  • Perioperative/Postoperative Complications
    • Dallas, Texas
    • +1 more
    May 9, 2022

    Vascular Diseases Trial in Paris (use of digital tablet)

    Terminated
    • Vascular Diseases
    • use of digital tablet
    • Paris, France
      Groupe Hospitalier Paris Saint-Joseph
    Oct 31, 2022

    Advanced Solid Tumor Trial (SHR-A1921;)

    Not yet recruiting
    • Advanced Solid Tumor
    • (no location specified)
    Feb 28, 2023

    Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))

    Not yet recruiting
    • Uncomplicated Plasmodium Falciparum Malaria
    • (no location specified)
    Feb 17, 2023

    Atrial Fibrillation, Left Atrial Appendage Occlusion, Silent Cerebral Embolism Trial in Nanjing (aspirin and clopidogrel,

    Recruiting
    • Atrial Fibrillation
    • +2 more
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Jan 3, 2023

    Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

    Not yet recruiting
    • Relapsed/Refractory Non-Hodgkin Lymphoma
    • Duarte, California
    • +1 more
    Oct 13, 2023

    Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and

    Not yet recruiting
    • Disability or Chronic Disease Leading to Disablement
    • +2 more
    • Surgical flap and anti-bacterial agents
    • Garches, France
      Department of Physical Medicine and Rehabilitation, Raymond Poin
    Feb 1, 2023

    Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)

    Recruiting
    • Solid Tumor
    • Chuo-ku, Tokyo, Japan
      National Cancer Center Hospital
    Jun 14, 2023

    NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • (no location specified)
    Sep 6, 2023

    Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

    Not yet recruiting
    • Cancer
    • +6 more
    • (no location specified)
    Oct 16, 2023

    Atherosclerosis, Adherence, Medication, Tolerance Trial in Kumasi (Polycap)

    Completed
    • Atherosclerosis
    • +2 more
    • Kumasi, Ghana
      Kwame Nkrumah University of Science & Technology
    Sep 29, 2022

    Thrombotic Thrombocytopenic Purpura Trial (Caplacizumab, Corticosteroids, anti-CD20 antibody)

    Not yet recruiting
    • Thrombotic Thrombocytopenic Purpura
    • (no location specified)
    Aug 8, 2022

    Ovarian Cancer, Lung Adenocarcinoma Trial in United States (AZD5335, AZD5305)

    Not yet recruiting
    • Ovarian Cancer
    • Lung Adenocarcinoma
    • Duarte, California
    • +6 more
    Mar 21, 2023

    Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)

    Completed
    • Crohn's Disease
    • Ulcerative Colitis
    • Immuno monitoring
    • Montpellier, France
      University hospital
    Dec 13, 2022

    IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)

    Not yet recruiting
    • Inflammatory Bowel Diseases
    • Biological Substance; Adverse Effect
    • Azithromycin Pill
    • Placebo
    • Haifa, Israel
      Rambam Health Care Campus
    Oct 25, 2022

    Risk of NSAIDs on Anastomotic Leak for Rectal Surgery

    Recruiting
    • Anastomotic Leak
    • Anti-Inflammatory Agents, Non-Steroidal
      • Chongqing, None Selected, China
        Army Medical Center
      Nov 24, 2023

      Myeloproliferative Neoplasia With Normal CBC and Thrombotic

      Recruiting
      • Thrombotic Patients
      • +2 more
        • Nantes, Loire-Atlantique, France
          Nantes University Hospital
        Sep 8, 2021

        Tumors Trial run by the NCI (Nilotinib and Paclitaxel)

        Recruiting
        • Neoplasms
        • Nilotinib and Paclitaxel
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 19, 2023

        Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)

        Recruiting
        • Mild Cognitive Impairment
        • Alzheimer Disease
        • Canakinumab
        • Placebo
        • Charlestown, Massachusetts
        • +11 more
        Nov 11, 2022

        Osteoarthritis, Knee Trial in Vail (Fisetin, Losartan, Placebo - Losartan)

        Recruiting
        • Osteoarthritis, Knee
        • Vail, Colorado
          The Steadman Clinic
        Oct 6, 2022

        Atrial Fibrillation Trial in Seoul (NOAC monotherapy, Dual therapy with apixaban and clopidogrel)

        Recruiting
        • Atrial Fibrillation
        • NOAC monotherapy
        • Dual therapy with apixaban and clopidogrel
        • Seoul, Korea, Republic of
          Severance Cardiovascular Hospital, Yonsei University Health Syst
        Sep 10, 2021